Global Autologous Matrix-induced Chondrogenesis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

January 2019 | 120 pages | ID: GE2A0A0483BEN
GlobalInfoResearch

Abstracts

utologous matrix-induced chondrogenesis (AMIC) is a 1-step cartilage restoration technique that combines microfracture with the use of an exogenous scaffold.

Scope of the Report:

This report focuses on the Autologous Matrix-induced Chondrogenesis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The functional principle of microfracturing is based on the release of multipotent mesenchymal progenitor cells, cytokines and growth factors from the subchondral bone. 
The worldwide market for Autologous Matrix-induced Chondrogenesis is expected to grow at a CAGR of roughly 8.0% over the next five years, will reach 160 million US$ in 2023, from 100 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• JRI Orthopaedics Ltd
• BioTissue
• Anika Therapeutics
• B. Braun Melsungen
• Arthro-Kinetics
• Geistlich Pharma
• CartiHeal
• Matricel
• Smith & Nephew
• Zimmer Biomet Holdings

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Hyaluronic Acid
• Collagen
• Polyethylene Glycol (PEG)
• Poly Lactic-Co-Glycolic Acid (PGLA)

Market Segment by Applications, can be divided into

• Knees Joint
• Other

There are 15 Chapters to deeply display the global Autologous Matrix-induced Chondrogenesis market.

Chapter 1, to describe Autologous Matrix-induced Chondrogenesis Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Autologous Matrix-induced Chondrogenesis, with sales, revenue, and price of Autologous Matrix-induced Chondrogenesis, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Autologous Matrix-induced Chondrogenesis, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Autologous Matrix-induced Chondrogenesis market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Autologous Matrix-induced Chondrogenesis sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Autologous Matrix-induced Chondrogenesis Introduction
1.2 Market Analysis by Type
  1.2.1 Hyaluronic Acid
  1.2.2 Collagen
  1.2.3 Polyethylene Glycol (PEG)
  1.2.4 Poly Lactic-Co-Glycolic Acid (PGLA)
1.3 Market Analysis by Applications
  1.3.1 Knees Joint
  1.3.2 Other
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 JRI Orthopaedics Ltd
  2.1.1 Business Overview
  2.1.2 Autologous Matrix-induced Chondrogenesis Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 BioTissue
  2.2.1 Business Overview
  2.2.2 Autologous Matrix-induced Chondrogenesis Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 BioTissue Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Anika Therapeutics
  2.3.1 Business Overview
  2.3.2 Autologous Matrix-induced Chondrogenesis Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Anika Therapeutics Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 B. Braun Melsungen
  2.4.1 Business Overview
  2.4.2 Autologous Matrix-induced Chondrogenesis Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Arthro-Kinetics
  2.5.1 Business Overview
  2.5.2 Autologous Matrix-induced Chondrogenesis Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Geistlich Pharma
  2.6.1 Business Overview
  2.6.2 Autologous Matrix-induced Chondrogenesis Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Geistlich Pharma Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 CartiHeal
  2.7.1 Business Overview
  2.7.2 Autologous Matrix-induced Chondrogenesis Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 CartiHeal Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Matricel
  2.8.1 Business Overview
  2.8.2 Autologous Matrix-induced Chondrogenesis Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Matricel Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Smith & Nephew
  2.9.1 Business Overview
  2.9.2 Autologous Matrix-induced Chondrogenesis Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Smith & Nephew Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Zimmer Biomet Holdings
  2.10.1 Business Overview
  2.10.2 Autologous Matrix-induced Chondrogenesis Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL AUTOLOGOUS MATRIX-INDUCED CHONDROGENESIS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Autologous Matrix-induced Chondrogenesis Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Autologous Matrix-induced Chondrogenesis Manufacturer Market Share in 2017
  3.3.2 Top 6 Autologous Matrix-induced Chondrogenesis Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL AUTOLOGOUS MATRIX-INDUCED CHONDROGENESIS MARKET ANALYSIS BY REGIONS

4.1 Global Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Regions
  4.1.1 Global Autologous Matrix-induced Chondrogenesis Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Regions (2013-2018)
4.2 North America Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
4.3 Europe Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
4.5 South America Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

5 NORTH AMERICA AUTOLOGOUS MATRIX-INDUCED CHONDROGENESIS BY COUNTRIES

5.1 North America Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Countries
  5.1.1 North America Autologous Matrix-induced Chondrogenesis Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Countries (2013-2018)
5.2 United States Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
5.3 Canada Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
5.4 Mexico Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

6 EUROPE AUTOLOGOUS MATRIX-INDUCED CHONDROGENESIS BY COUNTRIES

6.1 Europe Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Countries
  6.1.1 Europe Autologous Matrix-induced Chondrogenesis Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Countries (2013-2018)
6.2 Germany Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
6.3 UK Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
6.4 France Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
6.5 Russia Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
6.6 Italy Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC AUTOLOGOUS MATRIX-INDUCED CHONDROGENESIS BY COUNTRIES

7.1 Asia-Pacific Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Autologous Matrix-induced Chondrogenesis Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Countries (2013-2018)
7.2 China Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
7.3 Japan Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
7.4 Korea Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
7.5 India Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA AUTOLOGOUS MATRIX-INDUCED CHONDROGENESIS BY COUNTRIES

8.1 South America Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Countries
  8.1.1 South America Autologous Matrix-induced Chondrogenesis Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
8.3 Argentina Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
8.4 Colombia Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA AUTOLOGOUS MATRIX-INDUCED CHONDROGENESIS BY COUNTRIES

9.1 Middle East and Africa Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Autologous Matrix-induced Chondrogenesis Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
9.3 UAE Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
9.4 Egypt Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
9.5 Nigeria Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
9.6 South Africa Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

10 GLOBAL AUTOLOGOUS MATRIX-INDUCED CHONDROGENESIS MARKET SEGMENT BY TYPE

10.1 Global Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Autologous Matrix-induced Chondrogenesis Sales and Market Share by Type (2013-2018)
  10.1.2 Global Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Type (2013-2018)
10.2 Hyaluronic Acid Sales Growth and Price
  10.2.1 Global Hyaluronic Acid Sales Growth (2013-2018)
  10.2.2 Global Hyaluronic Acid Price (2013-2018)
10.3 Collagen Sales Growth and Price
  10.3.1 Global Collagen Sales Growth (2013-2018)
  10.3.2 Global Collagen Price (2013-2018)
10.4 Polyethylene Glycol (PEG) Sales Growth and Price
  10.4.1 Global Polyethylene Glycol (PEG) Sales Growth (2013-2018)
  10.4.2 Global Polyethylene Glycol (PEG) Price (2013-2018)
10.5 Poly Lactic-Co-Glycolic Acid (PGLA) Sales Growth and Price
  10.5.1 Global Poly Lactic-Co-Glycolic Acid (PGLA) Sales Growth (2013-2018)
  10.5.2 Global Poly Lactic-Co-Glycolic Acid (PGLA) Price (2013-2018)

11 GLOBAL AUTOLOGOUS MATRIX-INDUCED CHONDROGENESIS MARKET SEGMENT BY APPLICATION

11.1 Global Autologous Matrix-induced Chondrogenesis Sales Market Share by Application (2013-2018)
11.2 Knees Joint Sales Growth (2013-2018)
11.3 Other Sales Growth (2013-2018)

12 AUTOLOGOUS MATRIX-INDUCED CHONDROGENESIS MARKET FORECAST (2018-2023)

12.1 Global Autologous Matrix-induced Chondrogenesis Sales, Revenue and Growth Rate (2018-2023)
12.2 Autologous Matrix-induced Chondrogenesis Market Forecast by Regions (2018-2023)
  12.2.1 North America Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)
  12.2.2 Europe Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)
  12.2.4 South America Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)
12.3 Autologous Matrix-induced Chondrogenesis Market Forecast by Type (2018-2023)
  12.3.1 Global Autologous Matrix-induced Chondrogenesis Sales Forecast by Type (2018-2023)
  12.3.2 Global Autologous Matrix-induced Chondrogenesis Market Share Forecast by Type (2018-2023)
12.4 Autologous Matrix-induced Chondrogenesis Market Forecast by Application (2018-2023)
  12.4.1 Global Autologous Matrix-induced Chondrogenesis Sales Forecast by Application (2018-2023)
  12.4.2 Global Autologous Matrix-induced Chondrogenesis Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Autologous Matrix-induced Chondrogenesis Picture
Table Product Specifications of Autologous Matrix-induced Chondrogenesis
Figure Global Sales Market Share of Autologous Matrix-induced Chondrogenesis by Types in 2017
Table Autologous Matrix-induced Chondrogenesis Types for Major Manufacturers
Figure Hyaluronic Acid Picture
Figure Collagen Picture
Figure Polyethylene Glycol (PEG) Picture
Figure Poly Lactic-Co-Glycolic Acid (PGLA) Picture
Figure Autologous Matrix-induced Chondrogenesis Sales Market Share by Applications in 2017
Figure Knees Joint Picture
Figure Other Picture
Figure United States Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure France Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure UK Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure China Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure India Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Autologous Matrix-induced Chondrogenesis Revenue (Value) and Growth Rate (2013-2023)
Table JRI Orthopaedics Ltd Basic Information, Manufacturing Base and Competitors
Table JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Type and Applications
Table JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BioTissue Basic Information, Manufacturing Base and Competitors
Table BioTissue Autologous Matrix-induced Chondrogenesis Type and Applications
Table BioTissue Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Anika Therapeutics Basic Information, Manufacturing Base and Competitors
Table Anika Therapeutics Autologous Matrix-induced Chondrogenesis Type and Applications
Table Anika Therapeutics Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table B. Braun Melsungen Basic Information, Manufacturing Base and Competitors
Table B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Type and Applications
Table B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Arthro-Kinetics Basic Information, Manufacturing Base and Competitors
Table Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Type and Applications
Table Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Geistlich Pharma Basic Information, Manufacturing Base and Competitors
Table Geistlich Pharma Autologous Matrix-induced Chondrogenesis Type and Applications
Table Geistlich Pharma Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CartiHeal Basic Information, Manufacturing Base and Competitors
Table CartiHeal Autologous Matrix-induced Chondrogenesis Type and Applications
Table CartiHeal Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Matricel Basic Information, Manufacturing Base and Competitors
Table Matricel Autologous Matrix-induced Chondrogenesis Type and Applications
Table Matricel Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Smith & Nephew Basic Information, Manufacturing Base and Competitors
Table Smith & Nephew Autologous Matrix-induced Chondrogenesis Type and Applications
Table Smith & Nephew Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Zimmer Biomet Holdings Basic Information, Manufacturing Base and Competitors
Table Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Type and Applications
Table Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Autologous Matrix-induced Chondrogenesis Sales by Manufacturer (2016-2017)
Figure Global Autologous Matrix-induced Chondrogenesis Sales Market Share by Manufacturer in 2016
Figure Global Autologous Matrix-induced Chondrogenesis Sales Market Share by Manufacturer in 2017
Table Global Autologous Matrix-induced Chondrogenesis Revenue by Manufacturer (2016-2017)
Figure Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Manufacturer in 2016
Figure Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Manufacturer in 2017
Figure Top 3 Autologous Matrix-induced Chondrogenesis Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Autologous Matrix-induced Chondrogenesis Manufacturer (Revenue) Market Share in 2017
Figure Global Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Global Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2013-2018)
Table Global Autologous Matrix-induced Chondrogenesis Sales by Regions (2013-2018)
Table Global Autologous Matrix-induced Chondrogenesis Sales Market Share by Regions (2013-2018)
Table Global Autologous Matrix-induced Chondrogenesis Revenue by Regions (2013-2018)
Figure Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Regions in 2013
Figure Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Regions in 2017
Figure North America Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Europe Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure South America Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure North America Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2013-2018)
Table North America Autologous Matrix-induced Chondrogenesis Sales by Countries (2013-2018)
Table North America Autologous Matrix-induced Chondrogenesis Sales Market Share by Countries (2013-2018)
Figure North America Autologous Matrix-induced Chondrogenesis Sales Market Share by Countries in 2013
Figure North America Autologous Matrix-induced Chondrogenesis Sales Market Share by Countries in 2017
Table North America Autologous Matrix-induced Chondrogenesis Revenue by Countries (2013-2018)
Table North America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries (2013-2018)
Figure North America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries in 2013
Figure North America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries in 2017
Figure United States Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Canada Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Mexico Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Europe Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2013-2018)
Table Europe Autologous Matrix-induced Chondrogenesis Sales by Countries (2013-2018)
Table Europe Autologous Matrix-induced Chondrogenesis Sales Market Share by Countries (2013-2018)
Table Europe Autologous Matrix-induced Chondrogenesis Revenue by Countries (2013-2018)
Figure Europe Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries in 2016
Figure Europe Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries in 2017
Figure Germany Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure UK Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure France Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Russia Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Italy Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Autologous Matrix-induced Chondrogenesis Sales by Countries (2013-2018)
Table Asia-Pacific Autologous Matrix-induced Chondrogenesis Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Autologous Matrix-induced Chondrogenesis Sales Market Share by Countries 2017
Table Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue by Countries (2013-2018)
Figure Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries 2017
Figure China Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Japan Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Korea Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure India Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Southeast Asia Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure South America Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2013-2018)
Table South America Autologous Matrix-induced Chondrogenesis Sales by Countries (2013-2018)
Table South America Autologous Matrix-induced Chondrogenesis Sales Market Share by Countries (2013-2018)
Figure South America Autologous Matrix-induced Chondrogenesis Sales Market Share by Countries in 2017
Table South America Autologous Matrix-induced Chondrogenesis Revenue by Countries (2013-2018)
Table South America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries (2013-2018)
Figure South America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries in 2017
Figure Brazil Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Argentina Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Colombia Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Autologous Matrix-induced Chondrogenesis Sales by Countries (2013-2018)
Table Middle East and Africa Autologous Matrix-induced Chondrogenesis Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Autologous Matrix-induced Chondrogenesis Sales Market Share by Countries in 2017
Table Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue by Countries (2013-2018)
Table Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries in 2013
Figure Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries in 2017
Figure Saudi Arabia Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure UAE Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Egypt Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure Nigeria Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Figure South Africa Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)
Table Global Autologous Matrix-induced Chondrogenesis Sales by Type (2013-2018)
Table Global Autologous Matrix-induced Chondrogenesis Sales Share by Type (2013-2018)
Table Global Autologous Matrix-induced Chondrogenesis Revenue by Type (2013-2018)
Table Global Autologous Matrix-induced Chondrogenesis Revenue Share by Type (2013-2018)
Figure Global Hyaluronic Acid Sales Growth (2013-2018)
Figure Global Hyaluronic Acid Price (2013-2018)
Figure Global Collagen Sales Growth (2013-2018)
Figure Global Collagen Price (2013-2018)
Figure Global Polyethylene Glycol (PEG) Sales Growth (2013-2018)
Figure Global Polyethylene Glycol (PEG) Price (2013-2018)
Figure Global Poly Lactic-Co-Glycolic Acid (PGLA) Sales Growth (2013-2018)
Figure Global Poly Lactic-Co-Glycolic Acid (PGLA) Price (2013-2018)
Table Global Autologous Matrix-induced Chondrogenesis Sales by Application (2013-2018)
Table Global Autologous Matrix-induced Chondrogenesis Sales Share by Application (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Autologous Matrix-induced Chondrogenesis Sales, Revenue and Growth Rate (2018-2023)
Table Global Autologous Matrix-induced Chondrogenesis Sales Forecast by Regions (2018-2023)
Table Global Autologous Matrix-induced Chondrogenesis Market Share Forecast by Regions (2018-2023)
Figure North America Sales Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)
Figure Europe Sales Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)
Figure Asia-Pacific Sales Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)
Figure South America Sales Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)
Figure Middle East and Africa Sales Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)
Table Global Autologous Matrix-induced Chondrogenesis Sales Forecast by Type (2018-2023)
Table Global Autologous Matrix-induced Chondrogenesis Market Share Forecast by Type (2018-2023)
Table Global Autologous Matrix-induced Chondrogenesis Sales Forecast by Application (2018-2023)
Table Global Autologous Matrix-induced Chondrogenesis Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List